Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):585–593. doi: 10.1097/QAI.0000000000002079

Figure 1b:

Figure 1b:

Changes in level of soluble inflammatory makers pre- and post-EFV switch measured by ELISA. sCD14, IP-10, sCD163, MCP-1, Il-6, I-FABP, LPS, TNFRI were measured. Only those with significant changes are presented: A) sCD14 with mean decrease of 482.9 ng/ml, B) I-FABP with meanS increase of 227.3 pg/ml, and C) TNFR1 with mean increase of 51.4 pg/ml.